2021 RESEARCH
- Archives -Study shows MISSION wraparound services boost outcomes for drug court clients
An evidence-based wraparound service model that reduces barriers to care was shown to enhance drug treatment courts’ effectiveness in improving criminal justice and behavioral health outcomes among participants with co-occurring mental health and substance use disorders, according to a pilot study led by UMass Medical School.
‘Vaper to Vaper’ program to involve teens in getting peers to quit e-cigarettes
Researchers from UMass Medical School are working to develop and test mobile technology involving peer messaging and coaching to help adolescents quit using e-cigarettes.
UMass Medical School receives $2.8 million grant for advanced cryo-EM microscope
Roger Davis, PhD, FRS, and the Cryo-EM Core facility at UMass Medical School have received $2.8 million from The Massachusetts Life Sciences Center to purchase an advanced Glacios cryo-electron microscope from Thermo Fisher Scientific.
UMass Medical School researchers to evaluate treatment options for early COVID-19 infection
UMass Medical School is participating in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which is evaluating investigational agents for treating early COVID-19.
Serial rapid antigen testing on par with PCR COVID-19 tests, RADx team reports
A longitudinal study co-authored by UMass Medical School researchers as part of the National Institutes of Health’s Rapid Acceleration of Diagnostics initiative reported that PCR testing for SARS-CoV-2 and rapid antigen testing were equally effective in detecting infection when tests were given at least twice per week.
Cantor lab rethinks how common chemotherapy drug used in breast and ovarian cancer works
Research from the lab of Sharon Cantor, PhD, provides a new understanding of a PARP inhibitor, a chemotherapy drug commonly used against breast and ovarian cancer.
David Cochran receives grant from Eagles Foundation to study biomarker-driven drug treatment for autism
A research team led by David M. Cochran, MD, PhD, has been awarded $400,000 from the Eagles Autism Foundation to study a biomarker-driven pharmacological treatment for autism spectrum disorder.
Four interdisciplinary collaborations share mission to demystify devastating brain disorders
The Dan and Diane Riccio Fund for Neuroscience has awarded four teams of UMass Medical School researchers $50,000 seed grants for interdisciplinary collaborations leading to innovative discoveries that deepen understanding of normal brain function and what goes awry in neurological diseases.
UMMS researchers working to identify what information matters most to vaccine-hesitant patients
Researchers at UMass Medical School are working to identify what message doctors should convey to their patients to be most effective in increasing COVID-19 vaccine acceptance.
Chan Zuckerberg Initiative funds atomic-level imaging research in Grigorieff lab at UMMS
Nikolaus Grigorieff, PhD, and Bronwyn Lucas, PhD, have received a $1.3 million grant from the Chan Zuckerberg Initiative to develop new computational and data collection tools for locating specific molecules with near-atomic accuracy within cells using cryo-EM imaging technology.